Mersana Therapeutics Inc. (MRSN)
NASDAQ: MRSN
· Real-Time Price · USD
7.14
-0.28 (-3.77%)
At close: Aug 15, 2025, 3:59 PM
7.44
4.20%
After-hours: Aug 15, 2025, 06:16 PM EDT
Mersana Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 76.97M | 102.29M | 107.75M | 78.87M | 59M | 75.19M | 174.56M | 186.28M | 286.59M | 122.83M | 280.71M | 290.13M | 135.34M | 230.06M | 177.95M | 191.71M | 227.39M | 228.43M |
Short-Term Investments | n/a | n/a | 26.87M | 76.3M | 103.74M | 107.96M | 34.52M | 54.7M | 157.86M | 151.09M | 151.83M | 106.04M | 89.79M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 657K | n/a | n/a | n/a | 478K | 478K | 478K | 478K | 478K | 478K | n/a | 478K | 478K | 478K | 478K | 478K | 321K |
Other Long-Term Assets | 500K | n/a | 978K | 978K | 978K | n/a | n/a | n/a | 39K | 110K | 183K | 616K | 246K | 1.77M | 1.88M | 2.45M | 4.13M | 3.2M |
Receivables | 266K | n/a | n/a | 1M | 1.57M | n/a | n/a | n/a | n/a | n/a | 30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.9M | 3.9M | 2.28M | 4.39M | 4.65M | 4.39M | 4.97M | 8.75M | 10.5M | 7.89M | 8.51M | n/a | 11.95M | 11.41M | 10.95M | 7.65M | 6.04M | 3.52M |
Total Current Assets | 80.14M | 106.19M | 136.9M | 160.56M | 168.96M | 187.54M | 214.06M | 249.74M | 297.09M | 281.81M | 319.22M | 300.04M | 237.08M | 241.47M | 188.9M | 199.36M | 233.43M | 231.95M |
Property-Plant & Equipment | 3.93M | 5.63M | 6.78M | 8M | 9.19M | 10.36M | 11.53M | 12.69M | 13.4M | 13.8M | 14.46M | 14.2M | 14.55M | 14.55M | 14.86M | 15.3M | 15.65M | 12.44M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 4.43M | 6.28M | 7.76M | 8.97M | 10.16M | 10.84M | 12M | 13.17M | 13.91M | 14.39M | 15.12M | 14.81M | 15.27M | 16.8M | 17.21M | 18.23M | 20.25M | 15.96M |
Total Assets | 84.57M | 112.47M | 144.66M | 169.53M | 179.13M | 198.37M | 226.06M | 262.9M | 311M | 296.19M | 334.34M | 314.85M | 252.35M | 258.27M | 206.11M | 217.59M | 253.69M | 247.91M |
Account Payables | 2.92M | 4.37M | 4.33M | 2.03M | 3.01M | 3.09M | 7.32M | 12.95M | 16.92M | 18.16M | 13.95M | 13.73M | 8.16M | 9.78M | 12.32M | 5.87M | 10.65M | 11.74M |
Deferred Revenue | 20.18M | 23.71M | 22.17M | 31.37M | 29.34M | 25.62M | 28.15M | 21.59M | 20.5M | 28.77M | 30.61M | 30.92M | 26.23M | 16.58M | 3.94M | 3.96M | 3.97M | 3.98M |
Short-Term Debt | 20.62M | 12.5M | 12.5M | 11.46M | 11.99M | 5.21M | 2.08M | 3.14M | 3.02M | 2.9M | 240K | 2.7M | 2.59M | 2.4M | 239K | 2.24M | 2.35M | 1.57M |
Other Current Liabilities | 18.53M | 637K | 640K | 1.06M | 6.38M | 10.55M | 13.88M | 19.95M | 23.86M | 25.91M | 32.62M | 29.66M | 26.04M | 21.85M | 21.64M | 23.44M | 16.78M | 13.09M |
Total Current Liabilities | 59.34M | 58.16M | 62.46M | 68.3M | 62.18M | 53.41M | 63.64M | 67.93M | 74.92M | 83.4M | 91.53M | 88.79M | 71.47M | 56.46M | 47.52M | 44.02M | 40.47M | 34.92M |
Long-Term Debt | n/a | 7.9M | 10.95M | 14M | 17.05M | 20.1M | 23.15M | 25.16M | 25.08M | 25M | 24.93M | 24.85M | 24.78M | 24.7M | 24.63M | 5.08M | 4.87M | 5.01M |
Other Long-Term Liabilities | 78.38M | n/a | 8K | 21K | 626K | 638K | 1K | 67K | 76K | 140K | 203K | 266K | 328K | 389K | 974K | 1.03M | 288K | 318K |
Total Long-Term Liabilities | 78.38M | 85.18M | 91.71M | 100.18M | 108.52M | 116.98M | 125.52M | 142.78M | 146.28M | 148.5M | 150.75M | 135.83M | 46.85M | 61.28M | 36.85M | 18.02M | 17.7M | 15.05M |
Total Liabilities | 137.72M | 143.34M | 154.17M | 168.48M | 170.7M | 170.39M | 189.16M | 210.71M | 221.2M | 231.9M | 242.28M | 224.62M | 118.32M | 117.74M | 84.37M | 62.04M | 58.17M | 49.97M |
Total Debt | 20.62M | 24.62M | 28.6M | 31.5M | 32.31M | 33.08M | 33.83M | 34.34M | 35.03M | 35.68M | 36.3M | 36.84M | 37.43M | 37.67M | 38.18M | 19.22M | 19.76M | 16.31M |
Common Stock | n/a | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 11K | 11K | 10K | 10K | 9K | 7K | 7K | 7K | 7K |
Retained Earnings | -943.97M | -919.68M | -895.55M | -881.44M | -869.93M | -845.67M | -826.36M | -806.82M | -765.16M | -710.85M | -654.69M | -609.77M | -549.96M | -497.74M | -450.48M | -401.5M | -356.02M | -315.11M |
Comprehensive Income | n/a | n/a | 10K | 25K | -71K | -90K | 11K | 1K | -49K | 12K | -152K | -231K | -126K | 0.00 | n/a | n/a | n/a | n/a |
Shareholders Equity | -53.15M | -30.87M | -9.51M | 1.05M | 8.43M | 27.98M | 36.9M | 52.2M | 89.8M | 64.29M | 92.06M | 90.23M | 134.03M | 140.53M | 121.74M | 155.55M | 195.51M | 197.94M |
Total Investments | n/a | 657K | 26.87M | 76.3M | 103.74M | 108.44M | 35M | 54.7M | 157.86M | 151.09M | 151.83M | 106.04M | 89.79M | 478K | 478K | 478K | 478K | 321K |